Published in the Gastroenterology Journal, researchers have identified genetic variations that contribute to familial gastric cancer. Inherited mutations - which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types - impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care and new gastric cancer therapies.

Meanwhile, other researchers have developed a technique to identify patients who are more likely to suffer recurrence of gastric cancer based on the degree of abnormal DNA methylation. Check out the study here.

Kick back and add these videos from our YouTube page to your watchlist. We've spent the last few months refreshing our site to share the latest videos on gastric cancer research. Be sure to watch the latest video from Oncology Live of Dr. Salah-Eddin Al-Batran with the institute of Clinical Cancer Research in Frankfurt discussing the future of treatment in gastric cancer. He shares how immunotherapies continue to show promise, with results demonstrating the activity of nivolumab (Opdivo) in patients with unresectable advanced or recurrent gastric cancer.

Subscribe to our YouTube page now to stay in the loop on latest videos and updates from the Gastric Cancer Foundation and friends.

This is the last month of our KeVita #innerselfie campaign! KeVita continues to promote gastric cancer research by donating $2 to the Gastric Cancer Foundation for each inner selfie post shared with a photo. So grab your phone and strike a pose before the end of March! Stumped on what to share? Get ideas for creative posts here.